AML: Immuntoxin lieber fraktioniert verabreichen
نویسندگان
چکیده
منابع مشابه
Lieber Herr Bernays ! , Lieber
1. Gödel, Bernays, and Hilbert. The correspondence between Paul Bernays and Kurt Gödel is one of the most extensive in the two volumes of Gödel’s collected works devoted to his letters of (primarily) scientific, philosophical and historical interest. It ranges from 1930 to 1975 and deals with a rich body of logical and philosophical issues, including the incompleteness theorems, finitism, const...
متن کاملNasal Angiomyolipoma (AML) Mimicking Juvenile Nasopharyngeal Angiofibroma
Introduction: Angiomyolipoma (AML), a benign mesenchymal tumor that commonly arises from the kidney, may be associated with tuberous sclerosis complex and perivascular epithelioid cell tumors (PEComas). Nasal angiomyolipoma is very rare and usually occurs in elderly individuals with epistaxis and nasal obstruction. Case Report: We report a rare case of nasal angiomyoli...
متن کاملReasons for treating secondary AML as de novo AML.
In a Danish bi-regional registry-based study, we conducted an analysis of the incidence and clinical importance of secondary acute myeloid leukaemia (AML). In a total of 630 cases of AML, we found 157 (25%) cases of secondary AML. The secondary leukaemia arose from MDS (myelodysplastic syndrome) in 77 cases (49%), CMPD (chronic myeloproliferative disorder) in 43 cases (27%) and was therapy-rela...
متن کاملArginine addiction in AML.
In this issue of Blood, Miraki-Moud et al demonstrate that the majority of acute myeloid leukemias (AMLs) have low expression of argininosuccinate synthetase-1 (ASS1), rendering AML cell lines and primary AML blasts dependent on exogenous arginine and sensitized to arginine deprivation.
متن کاملTargeting treatment in AML.
Currently available chemotherapy has probably reached the limits of its potential in treating acute myeloid leukemia (AML). In considering the next steps it is appropriate to exploit on the one hand knowledge of the molecular, immunophenotypic and biological characteristics of the disease and on the other the biology of the patient. The aim is to move towards a more targeted approach. Immunophe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Im Focus Onkologie
سال: 2012
ISSN: 1435-7402
DOI: 10.1007/s15015-012-0346-1